BORDEAUX, France, September 26, 2013 /PRNewswire/ --
Successful
Conciliation Procedure and Resumption of Trading, New Funding
Provided
1. SUMMARY: SUCCESS OF THE CONCILIATION PROCEDURE AND SHARE
RETRADING
A conciliation process was entered into on 21/02/2013 between Europlasma, Crédit Suisse
Europlasma SPV LLC ("CS") and the lender and majority owner
of the waste and biomass to energy power plant in Morcenx (the
"CHO Morcenx Partner"), with the collaboration and support
from the public authorities, the key suppliers and its main banking
partner. As a result, the share trading was suspended 15/04/2013 to allow for confidentiality in the
conciliation procedure.
A conciliation procedure is voluntarily requested by a company
in financial difficulties to protect its best interests and those
of its shareholders, concluding in mutual agreements with its
creditors and partners. These agreements are aimed at ensuring the
long term viability of the company by improving the financing
conditions and providing cash flow relief.
After five months of conciliation, we are delighted to announce
that approval was given by the Commercial Court of Mont de Marsan
on 06/09/2013 on the memorandum of
settlement signed with the Group's partners. As such, the trading
in Europlasma shares will resume on Monday, 30 September 2013 at 9:00
a.m. CET in normal market conditions.
2. WHAT HAS TRANSPIRED OVER THE LAST 12 MONTHS?
CHO Power, the sub dedicated to Renewable Energies, completed
the construction of the 12MW WTE plant in Morcenx last year on
time, producing up to 6MW and proving the overall efficiency of the
CHO process and the business model.
However, the "Take-Over Date" of the plant was delayed, largely
due to deficiency of the gasifier in the process. In essence, the
gasifier was not allowing enough through put to be put through the
system, disabling the ability to ramp-up to full production. Given
the success with the rest of the CHO process, the decision was
taken to replace the faulty gasifer with one manufactured by PRM
Energy Systems Inc., a US company, with 31 years of experience and
over 25 installed gasifiers around the world. With this
replacement, the Board, Management, the reference Shareholder and
the CHO Morcenx partner are all confident that the plant will be
able to operate at full power.
These delays caused temporary cash flow challenges due to 3
effects: (i) delay in the revenue from the plant, (ii) delay in the
release of the EPC guarantees, and (iii) working capital needs to
support the interim period, forcing the Group to initiate a
conciliation procedure. This procedure was structured to protect
the best interests of the company and its shareholders and has
resulted in improved financing conditions, fair security packages
and cash flow relief, as can be seen below.
3. SUMMARY OF CONCILIATION PROCESS AND AGREEMENT
The conciliation started on Feb 21,
2013 and ended July 18, 2013,
with all parties aligned and the agreement signed, subsequently
ratified by the Court on September 6,
2013 and notified to the parties on September 16, 2013. As a result:
- Significant new funding by CS and the CHO Morcenx Partner has
begun in three tranches, mainly to finance the purchase of the new
gasifier and support the start of the ramp-up. Through this process
and their funding, our stakeholders have once again reiterated
their confidence and support.
As a result of the financing associated with the conciliation,
the Company's cash shortage issues have been solved for the
short-term. More specifically, the process itself resulted in the
implementation of the following measures:
- CS and the CHO Morcenx Partner have, on a pari passu basis,
granted CHO Power an additional loan of €4.6m at an interest rate
of 8%, retroactively increasing to 12% once the "Take-Over-Date" is
achieved, repayable by 8/2014. The funds are to be paid in 3
successive instalments. The first 2 instalments were paid on 7/2013
and 3rd is underway.
- The guarantees associated with this loan include standard
security packages (e.g pledge of securities and assets, certain
oversight on governance changes, regular preferential claim on new
money granted as part of the conciliation).
- Additionally, the loan conditions from 12/2012 have been
relaxed materially by both CS and the CHO Morcenx Partner,
including lowering the interest, extending the maturity date and
foregoing additional warrants due under the contract.
- Lastly, to meet working capital requirements for the ramp-up,
additional funds will be raised from shareholders and other
investors before the end of the year, subject to shareholders
approval at the next General Meeting.
Since 2008, CS has invested in several instances, for total
equity and debt of more than €19 million, repeatedly showing its
support and confidence in the company and its shares. As well, the
CHO Morcenx Partner has acted as lender for the majority of build
costs of the waste-to-energy plant in Morcenx (more than €25
million in project debt) and participated in the recent loan
financings (December 2012 and this
summer under the conciliation procedure), also exemplifying their
belief in the underlying technology and commercial aspirations of
the business.
4. OUTLOOK - KEY BUSINESS REORGANIZATION MEASURES
TAKEN
In addition to this new funding, several financial and
operational restructuring measures have been taken to ensure the
recovery of the Group's overall situation and focus its activities.
These include:
A. New organization structure to match
strategy and profitability focus
To improve its performance and visibility, the Group has decided
to sharpen its focus, with a renewed focus and vigour around its
core businesses. As such, an internal reorganisation is underway,
starting with the separation and grouping of all activities into
two distinct operating divisions, "Renewable Energies" and
"Hazardous Waste". New group structure and org charts have been
prepared to align the business units with the legal vehicles.
This will allow for efficient and bottom-line focused
management, the elimination of duplication of activities, closer
key performing indicators (KPI) monitoring, spending focused only
on profitable growth, as well as efficient fundraising in the
future. Marketing and sales have been reorganized with these
objectives.
B. Reorganization of CHO Power
Under the "Renewable Energies" division, in order to prepare CHO
Power for further growth, several measures have been taken, both
operationally and financially:
- Operationally, CHO Power has been reorganized so that it houses
all relevant staff, technology, activities and contracts related to
the CHO process. This will allow for a proper valuation of the
activities, accruing direct value to the Europlasma shareholders
(which owns 100% of CHO Power). As the growth driver of the
business, the Board wants to ensure that the value of this division
is discernible, as it believes in its technology differentiation,
financed pipeline and ability to develop world-class projects.
- Financially, to strengthen the capital base of CHO Power at the
head of the "Renewable Energies" segment, its share capital was
increased by €24 million via the incorporation of debt, and then
reduced by €11 million via the clearance of prior losses. Following
these transactions, the share capital of CHO Power amounts to
€14,393,224. Europlasma's interest in CHO Power is unchanged at
100%.
These measures have no material cash effect on the group but
allows CHO Power a clean balance sheet to grow over the coming
years, both through its pipeline (see below in next section) as
well as through the debt markets.
C. Set up of CHOPEX
As part of the CHO Power reorganization, the incorporation in
July of CHOPEX, a company wholly owned by CHO Power, dedicated to
the operation of the waste-to-energy plant in Morcenx and the
training of operating personnel for new plants in the future.
Operating personnel at the Morcenx plant, initially recruited by
Inertam, and the O&M (operation and maintenance) contract,
originally awarded to Inertam, have been transferred to CHOPEX.
D. Sale of non-core assets and
discontinuation of non-core activities
The disposal of Europe Environnement, 51% owned, is underway.
Several potential buyers have expressed interest, and the
transaction is expected to close early 2014. This operation is in
line with the desire to focus on core activities only as well as
will have the added benefit of bringing in additional cash
resources into the Group.
E. Establishment of moratoriums
(public authorities and suppliers)
The public authorities, through the General Directorate of
Public Finance, have provided the Group with support by
rescheduling the payment of significant tax and social security
liabilities. The Group has also received the support of its key
suppliers and its main banking partner, which have agreed to defer
certain payments.
F. Preference shares converted into
ordinary shares
As of this day, all of the Europlasma's preference shares have
been converted into ordinary shares. Share capital amounts to
€15,764,735, consisting of 15,764,735 ordinary shares.
G. Overall effect on financial
results
The delay in the Take-Over-Date, the decision to replace the
gasifier, and the implementation of the reorganization measures
have all had a significant impact on the financial statements for
fiscal 2012, though most of these effects are accounting,
non-recurring and non-cash. In addition, significant asset
impairments have been recorded in view of the uncertainties and
risks. Please see the accompanying press release. The Board
believes that the conservatism taken in preparing the financial
statements, combined with the focused approach to our business,
will result in a clean slate with which to approach our growth over
the coming years.
H. Effect on senior management
As was reported on 11/7/2013, the Board of Directors put an end
to Mr. Pineau's executive positions. He also resigned from his
Director's seat. Mr. Marchal, current Director, was appointed as
acting CEO for a 6 month period.
In the meantime, the Board has engaged with a top-tier executive
search firm to find a permanent replacement to Mr. Pineau, where
the process is very advanced and the final candidates have been
chosen. The new hire will be a world-class CEO, with deep and
relevant experience, who will drive the company's growth going
forward, focusing solely on value creation for the company and
shareholders. The Board and Management want to assure the
shareholders that they take this step very seriously and will
ensure the continuity and success of the business.
5. OUTLOOK - FOCUSED VISION ON CORE BUSINESS AND
PROFITABILITY
The Group will devote itself exclusively to scaling both the
Hazardous Waste and the Renewable Energies businesses over the
medium term. Given the proven technologies in the Hazardous Waste
and Renewable Energies domains, a focused delivery of value
creation activities for each of these, supported by the Group's
achievements over the last 12 months, will drive the long-term
growth over the coming years:
A. "Hazardous Waste"
Notable progress over the last 12 months:
- The triennial comprehensive overhaul of the asbestos waste
processing unit was conducted this summer on budget and on time.
Technical issues encountered over the previous several months in
respect of the preparation of loads for the processing line have
been resolved. These changes, combined with the comprehensive
overhaul of the furnace, should accelerate production rates. The
plant has resumed operations on 20/09/2013, in line with the
production schedule.
- The plasma furnace designed and built by Europlasma under
the KNPP (Kozloduy Nuclear Power Plant) contract for treating
low-level radioactive waste was delivered to the customer in July.
The plant will be shipped to Bulgaria after disassembly. Europlasma has
also demonstrated the performance of the plasma furnace to key
players in the nuclear industry who had expressed an interest. The
presentation was made using representative non-radioactive
waste.
Expected value creation over the medium and long term:
- The Management believes that the Inertam and KNPP units
provide the proof points necessary to scale the Hazardous Waste
business significantly. A strategic market assessment is currently
being carried out to understand where the most profitable market
segments lie and what the most efficient approach to such markets
is. The Board and Management are very confident about these
business opportunities and will update all shareholders on the
progress over the coming months.
B. "Renewable Energies"
Notable progress over the last 12 months:
- Since its construction was completed last summer, the WTE
power plant in Morcenx has proven its overall efficiency, thanks in
part to the wood dryer equipment connected.
- Given the technical difficulties and thanks to the funding
form the conciliation, the old gasifier at the plant has been
dismantled, with the new gasifier having been ordered. Engineering
studies have been completed and installation and connection work on
the new gasifier will continue until December 2013, allowing the plant to resume
operations in early 2014. The new "Take-Over Date" is 28 February 2014.
- The first four test campaigns of the KIWI (Kobelco
Industrial CHO poWer gasIfication) R&D programme, carried out
in 2012/13 in partnership with Kobelco (former Kobe Steel), have been highly successful,
particularly in respect of the destruction of tars using the
Turboplasma system.
Expected value creation over the medium and long term:
- The CHO Power business remains the key driver of value
creation for Europlasma. With the gasifier change and once the WTE
power plant is up and running, Management will focus on developing
the pipeline it has kept "warm", with the added benefit of the
financing being made available in large part by the CHOM Morcenx
partner. With financing exclusivity for 8 plants across different
countries, CHO Power is poised for strong growth over the coming
years.
- Additionally, the KIWI platform mentioned above will provide
the Group with an added source of competitive advantage, which when
coupled with its proven technology at the Morcenx plant, will turn
CHO Power into a world leader in plasma gasification. The
combination of the Turboplasma system with the gasifier will allow
for the CHO process to be seamlessly integrated into potential
facilities.
6. WHAT DOES THIS ALL MEAN FOR OUR
SHAREHODERS?
The Management and the Board would like again to thank all
shareholders for their patience and understanding as the Group has
undergone this conciliation process. With the reiterated support of
our key stakeholders, the Group is poised to embark on a new era of
profitable and focused growth. The world-class technologies,
associated pipelines and business opportunities, combined with the
support and continuity from our financing partners, new Management
and cash flow relief from the conciliation, should all work to
provide strong and profitable growth opportunities over the
medium-term, accruing direct value to our loyal and existing
shareholders.
7. FINANCIAL CALENDAR
25 September 2013:
Annual General Meeting notice (BALO)
26 September 2013:
Release of the FY 2012 consolidated results + 2012 Group
financial statements
30 September 2013:
Resumption of trading
31 October 2013:
Release of the HY Unaudited 2013 results
08 November 2013:
General Meeting of Shareholders
Contact:
François MARCHAL, Acting C.E.O.
Tel: +33-556-497-000
contactbourse@europlasma.com